The sales of antibacterial medicines in Australia are forecasted to grow from 11.6 USD per capita in 2024 to 12.2 USD per capita in 2028. Compared to the previous year, the sales in 2024 mark an increase from 11.4 USD per capita in 2023. The year-on-year percentage variations reflect a consistent growth, with increments of approximately 1.7% to 1.9% annually. Over the last two years, there has been a steady increase, highlighting a positive trend. The compound annual growth rate (CAGR) over the next five years is expected to be around 1.7%.
Future trends to watch for include advancements in antibacterial treatments, the impact of global and local health policies on antibacterial drug usage, and potential market saturation. Healthcare improvements and rising awareness about antibacterial resistance may also influence market dynamics. Additionally, economic conditions and changes in consumer behavior towards over-the-counter vs. prescription-based antibacterial medicines will play crucial roles.
